Olimp DAA Xtreme Prolact - Block 60 Tablets

The dietary supplement Olimp DAA Xtreme Prolact - Block is a high-quality product that provides DAA, i.e., D-aspartic acid. The composition also contains vitamins: E and B6 as well as zinc. The formula is available in a convenient tablet form.

D-aspartic acid is one of two forms of the amino acid aspartic acid. The other form is L-aspartate. D-AA can be used as a temporary testosterone booster for infertile men and athletes. D-aspartate can affect the testes via NMDA receptors, which are present in the testes in both Leydig and Sertoli cells. D-aspartate stimulates testosterone synthesis even when there is no stimulation by human chorionic gonadotropin, the hormone naturally responsible for the production of the mentioned hormone. [1]

Zinc contributes to the maintenance of normal testosterone levels in the blood and has a positive effect on reproductive function [ID 297]. It is also involved in DNA synthesis and cell division [ID 292]. It also contributes to the maintenance of healthy skin and bones [ID 293,295]. Furthermore, zinc is involved in the normal metabolism of fatty acids [ID 302]. Additionally, it shows, like vitamin E, antioxidant effects [ID 294].

Vitamin B6 contributes to the maintenance of normal protein and glycogen metabolism [ID 65]. Furthermore, it contributes to the normal formation of red blood cells [ID 67]. It has a positive effect on the function of the nervous system [ID 66]. Furthermore, it contributes to the maintenance of normal homocysteine metabolism [ID 73]. In excess, this amino acid can be very dangerous to health, particularly for the cardiovascular system.

In summary, the dietary supplement Olimp DAA Xtreme Prolact - Block is a high-quality product that combines valuable active ingredients: DAA, zinc, vitamin B6, and vitamin E. It has a simple and safe composition and a convenient tablet form.

1.Nagata Y, Homma H, Matsumoto M, Imai K. Stimulation of steroidogenic acute regulatory protein (StAR) gene expression by D-aspartate in rat Leydig cells. FEBS Lett. 1999 Jul 9;454(3):317-20. doi: 10.1016/s0014-5793(99)00840-6. PMID: 10431830.